- Home
- SLGB vs BTMD Comparison
SLGB vs BTMD Comparison
Compare SLGB & BTMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SLGB | BTMD |
|---|---|---|
| Founded | 2017 | 2012 |
| Country | Hong Kong | United States |
| Employees | N/A | N/A |
| Industry | Integrated Freight & Logistics | Medicinal Chemicals and Botanical Products |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 56.3M | 64.4M |
| IPO Year | N/A | 2021 |
Fundamental Metrics
Financial Performance| Metric | SLGB | BTMD |
|---|---|---|
| Price | $0.90 | $2.22 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $2.83 |
| AVG Volume (30 Days) | ★ 921.7K | 334.7K |
| Earning Date | 05-16-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 722.22 |
| EPS | N/A | ★ 0.74 |
| Revenue | N/A | ★ $192,219,000.00 |
| Revenue This Year | N/A | $2.03 |
| Revenue Next Year | N/A | $6.58 |
| P/E Ratio | $29.95 | ★ $3.00 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.60 | $1.27 |
| 52 Week High | $6.02 | $4.75 |
Technical Indicators
Market Signals| Indicator | SLGB | BTMD |
|---|---|---|
| Relative Strength Index (RSI) | 46.35 | 71.21 |
| Support Level | $0.60 | $2.02 |
| Resistance Level | $1.20 | $2.79 |
| Average True Range (ATR) | 0.12 | 0.16 |
| MACD | 0.03 | 0.10 |
| Stochastic Oscillator | 49.59 | 91.84 |
Price Performance
Historical ComparisonAbout SLGB Smart Logistics Global Limited Ordinary Shares
Smart Logistics Global Ltd is a contract logistics solution provider in the PRC focusing on industrial raw materials line-haul transportation business. the group focuses on the logistics digital ecosystem through innovation, digital analytics, and infrastructure establishment.
About BTMD Biote Corp.
Biote Corp operates a growth practice-building business within the hormone optimization space. It provides the necessary components to enable Biote-certified practitioners to establish, build, and successfully implement a program designed to optimize hormone levels using personalized solutions for their patient populations. The company derives revenue from United States and also has its presence in other countries.